By performing functional enrichment analysis on gene sets obtained from three perspectives, such as genes co-survival in TCGA-GBM and CGGA cohort, DEGs of high and low risk groups, and DEGs of IDH1 mutation compared with wild type, we identified five pathways significantly associated with poor prognosis in GBM patients. The gene discussed is IDH1; the disease is glioblastoma.